Blockade of TNF with etanercept stopped, without improving, disease progression in mice with mild, moderate and severe arthritis, resulting in an average clinical score 25 % lower than vehicle-treated mice, but 39 % higher than dual treatment. This evidence concerns the gene TNF and arthritic joint disease.